Four to 5 million American men are affected by hypogonadism. There are several challenges concerning hypogonadism, from the clinical diagnosis to the safety of testosterone therapy. It is important for clinicians to have an understanding of male hypogonadism and how to apply clinical guidelines in their practice to improve patient outcomes. This monograph examines issues facing physicians who manage patients with hypogonadism, offering information to help make more informed treatment decisions.

View monograph